TAKEDA PHARMACEUTICAL CO LTD

Q1 2024 13F Holdings Report, Stock Holdings

Signature - Title
Amit Singh - Senior Vice President and Head of Treasury
Location
Tokyo, Japan
Holdings as of
31 Mar 2024
Value $
$289,040,735
Num holdings
15
Filing time
13 Feb 2025, 06:28:24 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included HLVX, DNLI, PHAT, OVID, and STTK.
Previous filing
Q4 2023 - 13 Feb 2025
Next filing
Q2 2024 - 13 Feb 2025
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q1 compared to 2023 Q4 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Amit Singh Senior Vice President and Head of Treasury Tokyo, Japan 13 Feb 2025

Other Included Managers (1):

Num Name Location File Number
1 Takeda Vaccines, Inc. Cambridge, MA 028-24939